IBDEI092 ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11991,0)
 ;;=V10.02^^58^640^45
 ;;^UTILITY(U,$J,358.3,11991,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11991,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,11991,1,5,0)
 ;;=5^H/O Oral Cavity/Pharynx Cancer
 ;;^UTILITY(U,$J,358.3,11991,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,11992,0)
 ;;=V10.43^^58^640^46
 ;;^UTILITY(U,$J,358.3,11992,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11992,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,11992,1,5,0)
 ;;=5^H/O Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,11992,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,11993,0)
 ;;=V10.46^^58^640^47
 ;;^UTILITY(U,$J,358.3,11993,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11993,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,11993,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,11993,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,11994,0)
 ;;=V10.06^^58^640^48
 ;;^UTILITY(U,$J,358.3,11994,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11994,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,11994,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,11994,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,11995,0)
 ;;=V10.52^^58^640^49
 ;;^UTILITY(U,$J,358.3,11995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11995,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,11995,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,11995,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,11996,0)
 ;;=V10.04^^58^640^51
 ;;^UTILITY(U,$J,358.3,11996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11996,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,11996,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,11996,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,11997,0)
 ;;=V10.47^^58^640^52
 ;;^UTILITY(U,$J,358.3,11997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11997,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,11997,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,11997,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,11998,0)
 ;;=V10.83^^58^640^50
 ;;^UTILITY(U,$J,358.3,11998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11998,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,11998,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,11998,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,11999,0)
 ;;=201.90^^58^640^60
 ;;^UTILITY(U,$J,358.3,11999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11999,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,11999,1,5,0)
 ;;=5^Hodgkin's Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,11999,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,12000,0)
 ;;=200.20^^58^640^64
 ;;^UTILITY(U,$J,358.3,12000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12000,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,12000,1,5,0)
 ;;=5^Lymphoma,Burkitt's,Site Unspec
 ;;^UTILITY(U,$J,358.3,12000,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,12001,0)
 ;;=202.00^^58^640^66
 ;;^UTILITY(U,$J,358.3,12001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12001,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,12001,1,5,0)
 ;;=5^Lymphoma,Low-Grade,Site Unspec
 ;;^UTILITY(U,$J,358.3,12001,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,12002,0)
 ;;=200.10^^58^640^65
 ;;^UTILITY(U,$J,358.3,12002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12002,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,12002,1,5,0)
 ;;=5^Lymphoma,Int or High Grade,Site Unspec
 ;;^UTILITY(U,$J,358.3,12002,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,12003,0)
 ;;=203.00^^58^640^77
 ;;^UTILITY(U,$J,358.3,12003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12003,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,12003,1,5,0)
 ;;=5^Multiple Myeloma w/o Remission
 ;;^UTILITY(U,$J,358.3,12003,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,12004,0)
 ;;=203.01^^58^640^79
 ;;^UTILITY(U,$J,358.3,12004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12004,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,12004,1,5,0)
 ;;=5^Multiple Myeloma,In Remission
 ;;^UTILITY(U,$J,358.3,12004,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,12005,0)
 ;;=V10.21^^58^640^38
 ;;^UTILITY(U,$J,358.3,12005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12005,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,12005,1,5,0)
 ;;=5^H/O Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,12005,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,12006,0)
 ;;=180.9^^58^640^8
 ;;^UTILITY(U,$J,358.3,12006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12006,1,4,0)
 ;;=4^180.9
 ;;^UTILITY(U,$J,358.3,12006,1,5,0)
 ;;=5^Ca Cervix
 ;;^UTILITY(U,$J,358.3,12006,2)
 ;;=^267214
 ;;^UTILITY(U,$J,358.3,12007,0)
 ;;=203.02^^58^640^78
 ;;^UTILITY(U,$J,358.3,12007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12007,1,4,0)
 ;;=4^203.02
 ;;^UTILITY(U,$J,358.3,12007,1,5,0)
 ;;=5^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,12007,2)
 ;;=^336462
 ;;^UTILITY(U,$J,358.3,12008,0)
 ;;=V10.91^^58^640^44
 ;;^UTILITY(U,$J,358.3,12008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12008,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,12008,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,12008,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,12009,0)
 ;;=196.9^^58^640^62
 ;;^UTILITY(U,$J,358.3,12009,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12009,1,4,0)
 ;;=4^196.9
 ;;^UTILITY(U,$J,358.3,12009,1,5,0)
 ;;=5^Lymph Nodes
 ;;^UTILITY(U,$J,358.3,12009,2)
 ;;=^267313
 ;;^UTILITY(U,$J,358.3,12010,0)
 ;;=204.90^^58^640^63
 ;;^UTILITY(U,$J,358.3,12010,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12010,1,4,0)
 ;;=4^204.90
 ;;^UTILITY(U,$J,358.3,12010,1,5,0)
 ;;=5^Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,12010,2)
 ;;=^336854
 ;;^UTILITY(U,$J,358.3,12011,0)
 ;;=V10.82^^58^640^42
 ;;^UTILITY(U,$J,358.3,12011,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12011,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,12011,1,5,0)
 ;;=5^H/O Malig Melanoma
 ;;^UTILITY(U,$J,358.3,12011,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,12012,0)
 ;;=198.4^^58^640^76
 ;;^UTILITY(U,$J,358.3,12012,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12012,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,12012,1,5,0)
 ;;=5^Mets to Nervous System
 ;;^UTILITY(U,$J,358.3,12012,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,12013,0)
 ;;=202.80^^58^640^80
 ;;^UTILITY(U,$J,358.3,12013,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12013,1,4,0)
 ;;=4^202.80
 ;;^UTILITY(U,$J,358.3,12013,1,5,0)
 ;;=5^Non-Hodgkin's Lymphoma
 ;;^UTILITY(U,$J,358.3,12013,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,12014,0)
 ;;=V10.02^^58^640^53
 ;;^UTILITY(U,$J,358.3,12014,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12014,1,4,0)
 ;;=4^V10.02
 ;;^UTILITY(U,$J,358.3,12014,1,5,0)
 ;;=5^H/O of Malig Oral/Pharynx
 ;;^UTILITY(U,$J,358.3,12014,2)
 ;;=^295204
 ;;^UTILITY(U,$J,358.3,12015,0)
 ;;=V10.43^^58^640^54
 ;;^UTILITY(U,$J,358.3,12015,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12015,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,12015,1,5,0)
 ;;=5^H/O of Malig Ovary
 ;;^UTILITY(U,$J,358.3,12015,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,12016,0)
 ;;=V10.46^^58^640^55
 ;;^UTILITY(U,$J,358.3,12016,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12016,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,12016,1,5,0)
 ;;=5^H/O of Malig Prostate
 ;;^UTILITY(U,$J,358.3,12016,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,12017,0)
 ;;=V10.06^^58^640^56
 ;;^UTILITY(U,$J,358.3,12017,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12017,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,12017,1,5,0)
 ;;=5^H/O of Malig Rectum/Rectosigmoid/Anus
 ;;^UTILITY(U,$J,358.3,12017,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,12018,0)
 ;;=200.00^^58^640^81
 ;;^UTILITY(U,$J,358.3,12018,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12018,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,12018,1,5,0)
 ;;=5^Reticulosarcoma
 ;;^UTILITY(U,$J,358.3,12018,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,12019,0)
 ;;=V10.83^^58^640^57
 ;;^UTILITY(U,$J,358.3,12019,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12019,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,12019,1,5,0)
 ;;=5^H/O of Malig Skin
 ;;^UTILITY(U,$J,358.3,12019,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,12020,0)
 ;;=V10.04^^58^640^58
 ;;^UTILITY(U,$J,358.3,12020,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12020,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,12020,1,5,0)
 ;;=5^H/O of Malig Stomach
 ;;^UTILITY(U,$J,358.3,12020,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,12021,0)
 ;;=V10.47^^58^640^59
 ;;^UTILITY(U,$J,358.3,12021,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12021,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,12021,1,5,0)
 ;;=5^H/O of Malig Testis/Scrotum
 ;;^UTILITY(U,$J,358.3,12021,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,12022,0)
 ;;=829.0^^58^641^4
 ;;^UTILITY(U,$J,358.3,12022,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12022,1,4,0)
 ;;=4^829.0
 ;;^UTILITY(U,$J,358.3,12022,1,5,0)
 ;;=5^Fracture,Closed
 ;;^UTILITY(U,$J,358.3,12022,2)
 ;;=^48084
 ;;^UTILITY(U,$J,358.3,12023,0)
 ;;=829.1^^58^641^5
 ;;^UTILITY(U,$J,358.3,12023,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12023,1,4,0)
 ;;=4^829.1
 ;;^UTILITY(U,$J,358.3,12023,1,5,0)
 ;;=5^Fracture,Open
 ;;^UTILITY(U,$J,358.3,12023,2)
 ;;=^48096
 ;;^UTILITY(U,$J,358.3,12024,0)
 ;;=839.8^^58^641^2
 ;;^UTILITY(U,$J,358.3,12024,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12024,1,4,0)
 ;;=4^839.8
 ;;^UTILITY(U,$J,358.3,12024,1,5,0)
 ;;=5^Dislocation,Closed
 ;;^UTILITY(U,$J,358.3,12024,2)
 ;;=^25305
 ;;^UTILITY(U,$J,358.3,12025,0)
 ;;=839.9^^58^641^3
 ;;^UTILITY(U,$J,358.3,12025,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12025,1,4,0)
 ;;=4^839.9
 ;;^UTILITY(U,$J,358.3,12025,1,5,0)
 ;;=5^Dislocation,Open
 ;;^UTILITY(U,$J,358.3,12025,2)
 ;;=^274463
 ;;^UTILITY(U,$J,358.3,12026,0)
 ;;=848.9^^58^641^6
 ;;^UTILITY(U,$J,358.3,12026,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12026,1,4,0)
 ;;=4^848.9
 ;;^UTILITY(U,$J,358.3,12026,1,5,0)
 ;;=5^Sprain
 ;;^UTILITY(U,$J,358.3,12026,2)
 ;;=^123990
 ;;^UTILITY(U,$J,358.3,12027,0)
 ;;=949.0^^58^641^1
 ;;^UTILITY(U,$J,358.3,12027,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12027,1,4,0)
 ;;=4^949.0
 ;;^UTILITY(U,$J,358.3,12027,1,5,0)
 ;;=5^Burn
 ;;^UTILITY(U,$J,358.3,12027,2)
 ;;=^17590
 ;;^UTILITY(U,$J,358.3,12028,0)
 ;;=780.4^^58^642^41
 ;;^UTILITY(U,$J,358.3,12028,1,0)
 ;;=^358.31IA^5^2
